Bill > S04380

This bill establishes strict regulations on the use of antipsychotic drugs with black box warnings for elderly patients with dementia. The legislation defines key terms such as "off-label" use (prescribing a drug for a purpose different from its approved use), "black box warning" (a serious FDA warning about potentially fatal side effects), and "chemical restraint" (using antipsychotic drugs to sedate or control a patient without medical benefit). The bill prohibits using these drugs off-label for dementia patients in residential health care facilities, hospitals, and other care settings, with only very limited exceptions. Specifically, antipsychotic drugs may only be prescribed in emergency situations by a healthcare professional specially trained in dementia treatment, and only when absolutely necessary to protect the patient's or others' safety. When such a drug is used, the healthcare professional must immediately document the reason, dosage, and notify the patient's representative. Healthcare professionals who violate these provisions can be found guilty of professional misconduct. The bill aims to protect vulnerable elderly patients with dementia from unnecessary and potentially harmful medication practices, ensuring that antipsychotic drugs are used only as a last resort and with proper medical oversight.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S4380